mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |